Search

everythinglearnresearchcommunity

for

Search:↓

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Activating Notch in adult skin causes T cells and neural crest cells to gather, leading to skin issues.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Thymic transplantation normalized some T-cells but not others, maintaining immune function.

Patient-derived melanocytes can potentially treat vitiligo by restoring skin pigmentation.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

Immune cells affect hair growth and could lead to new hair loss treatments.

Safflower has been used in traditional medicine for centuries and shows promise in treating heart, brain, and inflammatory conditions, but more research is needed to ensure its safety.

Cheonggukjang may help prevent and manage various diseases and improve overall health, but its odor and safety concerns need addressing.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

Cavity macrophages gather on organ surfaces but don't really invade or help repair the organs after injury.

Lysophosphatidic acid is important for skin health and disease, and could be a target for new skin disorder treatments.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Consider benefits and risks of new alopecia treatments for safety.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Recognizing and treating skin symptoms in essential thrombocythemia is crucial for patient quality of life.

Rumex japonicus Houtt. may be an effective treatment for atopic dermatitis by reducing inflammation.

Substance from human umbilical cord blood cells promotes hair growth.

Hair follicle stem cells are promising for wound healing but require more research for safe clinical use.

People with alopecia areata have higher insulin resistance.

COVID-19 may harm male fertility and damage the reproductive system.

Non-invasive methods show promise for diagnosing skin diseases like psoriasis and lupus but need more research for regular use.

An imbalance in gut bacteria is linked to skin immune diseases and may affect their outcomes and related health issues.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.